CAMBRIDGE, Mass.--(BUSINESS WIRE)--Helicos BioSciences Corporation (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies, today announced the placement of a Helicos™ Genetic Analysis System at the Massachusetts General Hospital (MGH) Cancer Center in the laboratory of Daniel Haber, MD, PhD.
